RAMA SURESH, MD
Medical Oncology Physician · SAINT LOUIS, MO
Individual Active NPI 1093731226
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 628 | 84,076 | $5,718,390 | $2,078,820 | $1,651,387 |
| 2023 | 796 | 218,469 | $13,505,494 | $4,679,230 | $3,718,405 |
| 2022 | 739 | 183,929 | $10,963,303 | $3,699,469 | $2,948,042 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9263 | Injection, oxaliplatin, 0.5 mg | 8,900 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 7,500 | $0 | $0 |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 6,480 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 5,200 | $56 | $44 |
| J0897 | Injection, denosumab, 1 mg | 2,280 | $22 | $18 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 1,945 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,405 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 750 | $1 | $1 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 705 | $123 | $94 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 550 | $0 | $0 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 404 | $5 | $4 |
| J9190 | Injection, fluorouracil, 500 mg | 397 | $3 | $2 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 115986 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Missouri
- NPI 1023206158
- NPI 1043697063
- NPI 1881049187
- NPI 1215953534
- NPI 1528181997
- NPI 1740488766
- NPI 1710115951
- NPI 1700267986
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.